Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
SARS-CoV-2 疫苗 ChAdOx1 nCoV-19 的 1/2 期临床试验及其加强剂量可诱导多功能抗体反应
期刊:Nature Medicine
影响因子:58.7
doi:10.1038/s41591-020-01179-4
Jordan R Barrett #, Sandra Belij-Rammerstorfer #, Christina Dold #, Katie J Ewer #, Pedro M Folegatti #, Ciaran Gilbride #, Rachel Halkerston #, Jennifer Hill #, Daniel Jenkin #, Lisa Stockdale #, Marije K Verheul #, Parvinder K Aley, Brian Angus, Duncan Bellamy, Eleanor Berrie, Sagida Bibi, Mustaph
